Gilead Sciences
GILD
#131
Rank
C$205.69 B
Marketcap
C$165.78
Share price
-2.28%
Change (1 day)
28.65%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: C$205.69 Billion

As of December 2025 Gilead Sciences has a market cap of C$205.69 Billion. This makes Gilead Sciences the world's 131th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$205.69 B22.22%
2024C$168.30 B25.71%
2023C$133.88 B-8.37%
2022C$146.11 B25.91%
2021C$116.04 B24.62%
2020C$93.11 B-13.33%
2019C$107.44 B-1.64%
2018C$109.23 B-7.16%
2017C$117.65 B-7.2%
2016C$126.78 B-36.48%
2015C$199.60 B21.73%
2014C$163.97 B33.67%
2013C$122.66 B121.11%
2012C$55.47 B77.4%
2011C$31.27 B7.64%
2010C$29.05 B-29.08%
2009C$40.96 B-27.65%
2008C$56.61 B32.79%
2007C$42.63 B22.3%
2006C$34.85 B23.89%
2005C$28.13 B49.17%
2004C$18.86 B17%
2003C$16.12 B51.94%
2002C$10.61 B5%
2001C$10.10 B72.49%
2000C$5.85 B70.19%
1999C$3.44 B77.54%
1998C$1.93 B18.07%
1997C$1.64 B66.75%
1996C$0.98 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Gilead Sciences was reported to be:

C$205.67 Billion
by Nasdaq info icon info icon
C$205.69 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$235.58 B 14.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$159.58 B-22.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$543.45 B 164.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$28.54 B-86.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$35.16 B-82.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$202.37 B-1.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$701.88 B 241.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.268 T 516.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$344.95 B 67.70%๐Ÿ‡บ๐Ÿ‡ธ USA